WO2025170558 - A SOLID ORAL PHARMACEUTICAL FORMULATION COMPRISING AVATROMBOPAG
National phase entry is expected:
Publication Number
WO/2025/170558
Publication Date
14.08.2025
International Application No.
PCT/TR2025/050083
International Filing Date
04.02.2025
Title **
[English]
A SOLID ORAL PHARMACEUTICAL FORMULATION COMPRISING AVATROMBOPAG
[French]
FORMULATION PHARMACEUTIQUE ORALE SOLIDE COMPRENANT DE L'AVATROMBOPAG
Applicants **
SANOVEL ILAC SANAYI VE TICARET ANONIM SIRKETI
Inventors
SUNEL, Fatih
ATAK, Fadime Bilgehan
GULER, Tolga
Priority Data
2024/001353
06.02.2024
TR
Application details
| Total Number of Claims/PCT | * |
| Number of Independent Claims | * |
| Number of Priorities | * |
| Number of Multi-Dependent Claims | * |
| Number of Drawings | * |
| Pages for Publication | * |
| Number of Pages with Drawings | * |
| Pages of Specification | * |
| * | |
| Number of Office Actions | * |
| * | |
International Searching Authority |
Turkpatent
* |
| Recordal of a Change of the Applicant's Name/Address |
Change of Applicant's Name and Address
* |
| Type of Assignment |
The Standard Agent's Assignment
* |
| Applicant's Legal Status |
Legal Entity
* |
| * | |
| * | |
| * | |
| * | |
| * | |
| Entry into National Phase under |
Chapter I
* |
| Patent Delivery |
Send the Letters Patent by Courier
* |
| Translation |
|
* The data is based on automatic recognition. Please verify and amend if necessary.
** IP-Coster compiles data from publicly available sources. If this data includes your personal information, you can contact us to request its removal.
Quotation for National Phase entry
| Country | Stages | Total | |
|---|---|---|---|
| China | Filing, Examination, Granting | 2072 | |
| EPO | Filing, Examination, Granting | 9171 | |
| Japan | Filing, Examination, Granting | 2124 | |
| South Korea | Filing, Examination, Granting | 2071 | |
| USA | Filing, Examination, Granting | 4740 |
Total:
20,178
Contact Us
Abstract[English]
The present invention relates to a solid oral pharmaceutical formulation comprising avatrombopag maleate or a pharmaceutically acceptable salt, amorphous or crystalline form thereof and at least one filler, wherein the filler is lactose anhydrous. The present invention also relates to a simple, rapid, cost-effective, time-saving and industrially suitable process for preparing the solid oral pharmaceutical formulation.[French]
La présente invention concerne une formulation pharmaceutique orale solide comprenant du maléate d'avatrombopag ou un sel pharmaceutiquement acceptable, une forme amorphe ou cristalline de celui-ci et au moins une charge, la charge étant du lactose anhydre. La présente invention concerne également un procédé simple, rapide, économique, économe en temps et industriellement approprié pour préparer la formulation pharmaceutique orale solide.